edjohnson
Active member
- Joined
- Nov 18, 2011
- Messages
- 48
- Reason
- PALS
- Diagnosis
- 10/2011
- Country
- US
- State
- nc
- City
- emerald isle
If you plan to attend this webinar On Friday at 2 PM EST:
upcoming clinical trial of Mexiletine in patients with sporadic ALS
https://www1.gotomeeting.com/register/791699817
you will be able to ask questions if you are registered to attend. Suggest As many attendees as possible ask a version of these 2 questions:
Question 1, we know the FDA is open to new ideas, will you ask them to allow the trial to use historic placebo data rather than a new arm for placebo data? Eliminating the placebo arm will not harm the integrity of the trial results but will Eliminate expense and a burden on ALS patients, While preserving patients for other trials.
Question 2, Will you be willing to use the new algorithm that allows previous trial data to be used to shorten current trials, the algorithm recently Won the prize for life?
upcoming clinical trial of Mexiletine in patients with sporadic ALS
https://www1.gotomeeting.com/register/791699817
you will be able to ask questions if you are registered to attend. Suggest As many attendees as possible ask a version of these 2 questions:
Question 1, we know the FDA is open to new ideas, will you ask them to allow the trial to use historic placebo data rather than a new arm for placebo data? Eliminating the placebo arm will not harm the integrity of the trial results but will Eliminate expense and a burden on ALS patients, While preserving patients for other trials.
Question 2, Will you be willing to use the new algorithm that allows previous trial data to be used to shorten current trials, the algorithm recently Won the prize for life?